Skip to main content

Advertisement

Table 2 Clinicopathological and miR-141 correlation of the expression of an ovarian cancer tissue array (OVC1021). The 5-fold cut-off was determined by ROC analysis

From: MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis

Parameters n(=97) KLF12 expression
≤5-fold >5-fold p
Grade
 Low (1 + 2) 50 25 (50%) 25 (50%)  
 High (3) 46 24 (52%) 22 (48%) 0.841
Stage
 Early (1) 48 14 (29%) 34 (71%)  
 Late (2 + 3) 49 36 (73%) 13 (27%) 0.000*
Metastasis
 Yes 24 18 (75%) 6 (25%)  
 No 73 32 (44%) 41 (56%) 0.010*
miR-141
  ≤ 5 folds 50 14 (28%) 36 (72%)  
  > 5 folds 48 37 (77%) 11 (23%) 0.000*
  1. *P < 0.05